12:00 AM
 | 
Nov 02, 2009
 |  BC Week In Review  |  Company News  |  Other News

SciClone cancer news

SciClone will restructure and reduce headcount by seven (17%) to 34, with cuts primarily in research and development. In October, SciClone discontinued a...

Read the full 92 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Week In Review

Article Purchase

$30 USD
More Info >